SHAREHOLDERS' EQUITY - Narrative (Details) |
12 Months Ended | 61 Months Ended | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 26, 2023
shares
|
Nov. 17, 2022
USD ($)
$ / shares
shares
|
Jul. 18, 2021 |
Feb. 04, 2020
USD ($)
sales_agent
|
Mar. 31, 2024
USD ($)
$ / shares
shares
|
Mar. 31, 2023
USD ($)
$ / shares
shares
|
Mar. 31, 2024
USD ($)
$ / shares
shares
|
Oct. 11, 2023
shares
|
Oct. 10, 2023
shares
|
Aug. 02, 2022
USD ($)
|
Aug. 01, 2022
USD ($)
|
Aug. 31, 2021
USD ($)
|
Jul. 28, 2021
USD ($)
|
May 26, 2021
USD ($)
|
Mar. 04, 2019
USD ($)
|
|
Subsidiary or Equity Method Investee [Line Items] | |||||||||||||||
Common stock, shares authorized (in shares) | shares | 75,000,000 | 40,000,000 | 75,000,000 | 75,000,000 | 40,000,000 | ||||||||||
Repurchase authorized amount | $ 20,000,000 | $ 20,000,000 | |||||||||||||
Cancellation of treasury shares (in shares) | shares | 2,339,512 | ||||||||||||||
Public Equity Offering | |||||||||||||||
Subsidiary or Equity Method Investee [Line Items] | |||||||||||||||
Number of shares sold (in shares) | shares | 2,534,436 | ||||||||||||||
Gross proceeds received | $ 46,000,000 | ||||||||||||||
Net proceeds received | $ 44,100,000 | ||||||||||||||
Par value, common stock (in usd per share) | $ / shares | $ 18.15 | ||||||||||||||
Equity ATM Program | |||||||||||||||
Subsidiary or Equity Method Investee [Line Items] | |||||||||||||||
Maximum consideration threshold | $ 100,000,000 | $ 650,000,000 | $ 250,000,000 | $ 250,000,000 | $ 50,000,000 | ||||||||||
Number of additional sales agents | sales_agent | 2 | ||||||||||||||
Gross sales commission percentage | 1.50% | 2.00% | |||||||||||||
Number of shares sold (in shares) | shares | 8,733,315 | 8,435,462 | 25,346,437 | ||||||||||||
Weighted average price per share (in usd per share) | $ / shares | $ 21.09 | $ 19.11 | $ 20.87 | ||||||||||||
Gross proceeds received | $ 184,217,000 | $ 161,216,000 | $ 528,900,000 | ||||||||||||
Net proceeds received | 181,453,000 | $ 158,798,000 | 520,500,000 | ||||||||||||
Available under the Equity ATM Program | $ 121,100,000 | $ 121,100,000 | |||||||||||||
2010 Plan | Restricted Stock | |||||||||||||||
Subsidiary or Equity Method Investee [Line Items] | |||||||||||||||
Right to grant period | 10 years |